Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome

被引:5
|
作者
Tang, Binbin [1 ,2 ]
Hu, Yunlian [3 ,4 ]
Chen, Jianhui [3 ,4 ]
Su, Chengxia [3 ,4 ]
Zhang, Qian [3 ,4 ]
Huang, Chaoqun [3 ,4 ]
机构
[1] Tongde Hosp Zhejiang Prov, Outpatient Dept 2, Hangzhou, Peoples R China
[2] Hubei Univ Chinese Med, Clin Coll Tradit Chinese Med, Wuhan, Peoples R China
[3] Hubei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Wuhan, Peoples R China
[4] Hubei Univ Chinese Med, Clin Coll 1, Wuhan, Peoples R China
关键词
Fecal microbiota; Oral microbiota; Irritable bowel syndrome; Diarrhea; INFLAMMATION;
D O I
10.1016/j.heliyon.2023.e13114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: This study aimed at investigating the characteristics and correlation between oral (tongue coating) and fecal microbiota in patients with diarrheal irritable bowel syndrome (IBS-D).Methods: Fifty-two IBS-D patients were chosen, with ten healthy volunteers serving as the normal control group. Tongue coating samples and fecal samples of subjects were sequenced for the 16S rRNA gene (V4-V5). Bioinformatics analysis was done on the test data to investigate oral and fecal microbiota composition characteristics in IBS-D patients.Results: The microbial richness of tongue coating in IBS-D group was lower than that in the normal control group (P < 0.05). The beta diversity of tongue coating microbiota and fecal microbiota was significantly different in the IBS-D group compared to the normal control group (P < 0.05). Pseudomonadales (Pseudomonadaceae and Pseudomonas), Moraxellaceae, Parvimonas, Peptos-treptococcus, and Alloprevotella were considerably high in number the tongue coating samples of the IBS-D group in comparison to the normal control group. Similarly, the fecal samples from the IBS-D group were significantly enriched in Alphaproteobacteria, Pseudomonadales (Pseudomona-daceae and Pseudomonas), Acidaminococcaceae, Phascolarctobacterium, Alloprevotella, and Escher-ichia compared to the normal control group.Conclusions: The oral and fecal microbiotas of IBS-D patients differ from those of the control group; hence studying IBS-D from the perspective of the oral-gut microbiome axis is an interesting research avenue.
引用
收藏
页数:10
相关论文
共 50 条
  • [2] Characterization of the fecal microbiota in patients with diarrhea predominant irritable bowel syndrome
    Carroll, Ian M.
    Shen, Xiang Jun
    Keku, Temitope O.
    Sartor, R. Balfour
    Ringel, Yehuda
    GASTROENTEROLOGY, 2008, 134 (04) : A681 - A681
  • [3] METABOLIC ALTERATIONS TO FECAL GUT MICROBIOTA IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
    Kanazawa, Motoyori
    Miyamoto, Kentaro
    Oka, Kentaro
    Takahashi, Motomichi
    Kano, Michiko
    Fukudo, Shin
    GASTROENTEROLOGY, 2019, 156 (06) : S364 - S365
  • [4] Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
    Cui, Xiufang
    Wang, Haiyang
    Ye, Ziping
    Li, Yi
    Qiu, Xinyun
    Zhang, Hongjie
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [5] Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
    Xiufang Cui
    Haiyang Wang
    Ziping Ye
    Yi Li
    Xinyun Qiu
    Hongjie Zhang
    BMC Gastroenterology, 21
  • [6] Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation
    Yukari Tanaka
    Riu Yamashita
    Junko Kawashima
    Hiroshi Mori
    Ken Kurokawa
    Shinji Fukuda
    Yasuhiro Gotoh
    Keiji Nakamura
    Tetsuya Hayashi
    Yoshiyuki Kasahara
    Yukuto Sato
    Shin Fukudo
    Journal of Gastroenterology, 2022, 57 : 748 - 760
  • [7] Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation
    Tanaka, Yukari
    Yamashita, Riu
    Kawashima, Junko
    Mori, Hiroshi
    Kurokawa, Ken
    Fukuda, Shinji
    Gotoh, Yasuhiro
    Nakamura, Keiji
    Hayashi, Tetsuya
    Kasahara, Yoshiyuki
    Sato, Yukuto
    Fukudo, Shin
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 748 - 760
  • [8] Fecal Microbiota Transplant Effective for Irritable Bowel Syndrome
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (06) : 377 - 377
  • [9] Fecal microbiota transplantation for managing irritable bowel syndrome
    El-Salhy, Magdy
    Mazzawi, Tarek
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (05) : 439 - 445
  • [10] Is fecal microbiota transplantation currently a therapeutic option in patients with irritable bowel syndrome?
    Quera, Rodrigo
    Sedano, Rocio
    Nunez, Paulina
    REVISTA MEDICA DE CHILE, 2020, 148 (05) : 713 - 714